Kyverna Therapeutics, Inc. (KYTX)
5.15
-0.01
(-0.19%)
USD |
NASDAQ |
Nov 04, 16:00
5.12
-0.03
(-0.58%)
After-Hours: 19:39
Kyverna Therapeutics Market Cap : 317.09M for Nov. 4, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 03, 2026 | 317.70M |
| November 02, 2026 | 321.40M |
| October 30, 2026 | 349.10M |
| October 29, 2026 | 360.19M |
| October 28, 2026 | 362.65M |
| October 27, 2026 | 346.64M |
| October 26, 2026 | 324.48M |
| October 23, 2026 | 331.86M |
| October 22, 2026 | 352.80M |
| October 21, 2026 | 359.57M |
| October 20, 2026 | 371.88M |
| October 19, 2026 | 358.95M |
| October 16, 2026 | 349.10M |
| October 15, 2026 | 367.57M |
| October 14, 2026 | 350.03M |
| October 13, 2026 | 355.26M |
| October 12, 2026 | 382.35M |
| October 09, 2026 | 393.43M |
| October 08, 2026 | 380.50M |
| October 07, 2026 | 379.89M |
| October 06, 2026 | 379.27M |
| October 05, 2026 | 389.12M |
| October 02, 2026 | 382.97M |
| October 01, 2026 | 401.44M |
| September 30, 2026 | 418.68M |
| Date | Value |
|---|---|
| September 29, 2026 | 421.14M |
| September 28, 2026 | 419.91M |
| September 25, 2026 | 419.29M |
| September 24, 2026 | 430.38M |
| September 23, 2026 | 435.30M |
| September 22, 2026 | 462.39M |
| September 21, 2026 | 438.38M |
| September 18, 2026 | 439.00M |
| September 17, 2026 | 433.45M |
| September 16, 2026 | 424.83M |
| September 15, 2026 | 428.53M |
| September 14, 2026 | 455.62M |
| September 11, 2026 | 447.00M |
| September 10, 2026 | 452.54M |
| September 09, 2026 | 470.40M |
| September 08, 2026 | 496.87M |
| September 04, 2026 | 507.95M |
| September 03, 2026 | 514.11M |
| September 02, 2026 | 530.43M |
| September 01, 2026 | 514.11M |
| August 31, 2026 | 521.81M |
| August 28, 2026 | 515.34M |
| August 27, 2026 | 531.97M |
| August 26, 2026 | 530.12M |
| August 25, 2026 | 544.28M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.704B |
| Oncolytics Biotech, Inc. | 53.05M |
| Sangamo Therapeutics, Inc. | 48.47M |
| Sarepta Therapeutics, Inc. | 2.007B |
| Anixa Biosciences, Inc. | 113.09M |
Market Cap Related Metrics
| Price to Book Value | 1.915 |
| Price | 5.15 |
| Earnings Yield | -57.00% |